VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities.
Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants. Histopathology. 2015 Nov; 67(5):699-708.
View in:
PubMed
subject areas
Adaptor Proteins, Signal Transducing
Adolescent
Adult
Aged
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
Calcium-Binding Proteins
Female
Hemangioendothelioma, Epithelioid
Humans
Immunohistochemistry
Intracellular Signaling Peptides and Proteins
Male
Middle Aged
Oncogene Proteins, Fusion
Phosphoproteins
Reverse Transcriptase Polymerase Chain Reaction
Trans-Activators
Transcription Factors
Young Adult
authors with profiles
ALEXANDER LAZAR
DOLORES LOPEZ-TERRADA
WEI-LIEN WANG